Actavis Generics is a global pharmaceutical company focused on developing,
manufacturing ... In 1993, Actavis, then Watson, announced its initial public
offering (IPO) of shares of common stock. ......
Oct 31, 2012 ... Actavis (NYSE: ACT) is a global, integrated specialty pharmaceutical company
focused on developing, manufacturing and distributing generic, ...
May 13, 2016 ... MERCK & CIE v. WATSON LABORATORIES INC. 3 considered by the parties
was a joint venture to market and distribute MTHF. J.A. 1287–90 ...
The latest litigation news involving the company Watson Pharmaceuticals Inc. (
Watson Pharmaceuticals, Inc. (NYSE-WPI) is a global specialty pharmaceutical
company with approximately $3 billion in revenues, a broad product line and ...
May 16, 2016 ... ... in Merck & Cie v. Watson Laboratories, Inc., ANDA litigation over claim 4 of
U.S. Patent No. 6441168, which reads: A crystalline calcium salt ...
Oct 15, 2012 ... The Federal Trade Commission will require Watson Pharmaceuticals, Inc. and
Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz ...
Watson Pharmaceuticals President, CEO, and Director Paul M. Bisaro. Paul M.
Bisaro ..... Glassdoor. Glassdoor ® is a registered trademark of Glassdoor, Inc.
Jan 25, 2013 ... Watson Pharmaceuticals is no more. The generic drug company has officially
taken the name of its most recent acquisition target, Actavis ...
Nov 13 2012, Brief of respondent Watson Pharmaceuticals, Inc. filed. ... Feb 21
2013, Brief of respondents Par Pharmaceutical Companies, Inc. and Paddock ...